Literature DB >> 20682947

Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction.

Anand Prasad1, Jeffrey L Hastings, Shigeki Shibata, Zoran B Popovic, Armin Arbab-Zadeh, Paul S Bhella, Kazunobu Okazaki, Qi Fu, Martin Berk, Dean Palmer, Neil L Greenberg, Mario J Garcia, James D Thomas, Benjamin D Levine.   

Abstract

BACKGROUND: Congestive heart failure in the setting of a preserved left ventricular (LV) ejection fraction is increasing in prevalence among the senior population. The underlying pathophysiologic abnormalities in ventricular function and structure remain unclear for this disorder. We hypothesized that patients with heart failure with preserved ejection fraction (HFPEF) would have marked abnormalities in LV diastolic function with increased static diastolic stiffness and slowed myocardial relaxation compared with age-matched healthy controls. METHODS AND
RESULTS: Eleven highly screened patients (4 men, 7 women) aged 73±7 years with HFPEF were recruited to participate in this study. Thirteen sedentary healthy controls (7 men, 6 women) aged 70±4 years also were recruited. All subjects underwent pulmonary artery catheterization with measurement of cardiac output, end-diastolic volumes, and pulmonary capillary wedge pressures at baseline; cardiac unloading (lower-body negative pressure or upright tilt); and cardiac loading (rapid saline infusion). The data were used to define the Frank-Starling and LV end-diastolic pressure-volume relationships. Doppler echocardiographic data (tissue Doppler velocities, isovolumic relaxation time, propagation velocity of early mitral inflow , E/A-wave ratio) were obtained at each level of cardiac preload. Compared with healthy controls, patients with HFPEF had similar LV contractile function and static LV compliance but reduced LV chamber distensibility with elevated filling pressures and slower myocardial relaxation as assessed by tissue Doppler imaging.
CONCLUSIONS: In this small, highly screened patient population with hemodynamically confirmed HFPEF, increased end-diastolic static ventricular stiffness relative to age-matched controls was not a universal finding. Nevertheless, patients with HFPEF, even when well compensated, had elevated filling pressures, reduced distensibility, and increased diastolic wall stress compared with controls. In contrast, LV relaxation as assessed by tissue Doppler variables appeared consistently impaired in patients with HFPEF.

Entities:  

Mesh:

Year:  2010        PMID: 20682947      PMCID: PMC3716372          DOI: 10.1161/CIRCHEARTFAILURE.109.867044

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  36 in total

Review 1.  Ventricular diastole and the role of the pericardium.

Authors:  J V Tyberg; E R Smith
Journal:  Herz       Date:  1990-12       Impact factor: 1.443

2.  Ischemia induced systolic and diastolic dysfunction in anesthetized patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  H B van Wezel; J J Koolen; C A Visser; A Schuurhuis
Journal:  J Cardiothorac Anesth       Date:  1989-10

3.  Left ventricular pressure-volume and Frank-Starling relations in endurance athletes. Implications for orthostatic tolerance and exercise performance.

Authors:  B D Levine; L D Lane; J C Buckey; D B Friedman; C G Blomqvist
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

4.  Ischemia-induced diastolic dysfunction: new observations, new questions.

Authors:  M A Greenberg; M A Menegus
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

5.  Noninvasive determination of cardiac output by a modified acetylene rebreathing procedure utilizing mass spectrometer measurements.

Authors:  J H Triebwasser; R L Johnson; R P Burpo; J C Campbell; W C Reardon; C G Blomqvist
Journal:  Aviat Space Environ Med       Date:  1977-03

6.  Effective arterial elastance as index of arterial vascular load in humans.

Authors:  R P Kelly; C T Ting; T M Yang; C P Liu; W L Maughan; M S Chang; D A Kass
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

7.  Diastolic dysfunction: can it be diagnosed by Doppler echocardiography?

Authors:  Mathew S Maurer; Daniel Spevack; Daniel Burkhoff; Itzhak Kronzon
Journal:  J Am Coll Cardiol       Date:  2004-10-19       Impact factor: 24.094

8.  Contribution of external forces to left ventricular diastolic pressure. Implications for the clinical use of the Starling law.

Authors:  K Dauterman; P H Pak; W L Maughan; A Nussbacher; S Ariê; C P Liu; D A Kass
Journal:  Ann Intern Med       Date:  1995-05-15       Impact factor: 25.391

9.  Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia.

Authors:  J M Aroesty; R G McKay; G V Heller; H D Royal; A V Als; W Grossman
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

10.  Effect of aging and physical activity on left ventricular compliance.

Authors:  Armin Arbab-Zadeh; Erika Dijk; Anand Prasad; Qi Fu; Pilar Torres; Rong Zhang; James D Thomas; Dean Palmer; Benjamin D Levine
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

View more
  36 in total

1.  Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans.

Authors:  Naoki Fujimoto; Jeffrey L Hastings; Paul S Bhella; Shigeki Shibata; Nainesh K Gandhi; Graeme Carrick-Ranson; Dean Palmer; Benjamin D Levine
Journal:  J Physiol       Date:  2012-02-13       Impact factor: 5.182

Review 2.  Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives.

Authors:  Fayez El Shear
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

3.  Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications For Heart Failure Prevention.

Authors:  Erin J Howden; Satyam Sarma; Justin S Lawley; Mildred Opondo; William Cornwell; Douglas Stoller; Marcus A Urey; Beverley Adams-Huet; Benjamin D Levine
Journal:  Circulation       Date:  2018-01-08       Impact factor: 29.690

Review 4.  The pathophysiology of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

5.  Phenomapping for novel classification of heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah; Daniel H Katz; Senthil Selvaraj; Michael A Burke; Clyde W Yancy; Mihai Gheorghiade; Robert O Bonow; Chiang-Ching Huang; Rahul C Deo
Journal:  Circulation       Date:  2014-11-14       Impact factor: 29.690

Review 6.  Phenotypic spectrum of heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah; Daniel H Katz; Rahul C Deo
Journal:  Heart Fail Clin       Date:  2014-05-22       Impact factor: 3.179

7.  Haemodynamics of Heart Failure With Preserved Ejection Fraction: A Clinical Perspective.

Authors:  Mauro Gori; Attilio Iacovoni; Michele Senni
Journal:  Card Fail Rev       Date:  2016-11

8.  Impact of lifelong exercise "dose" on left ventricular compliance and distensibility.

Authors:  Paul S Bhella; Jeffrey L Hastings; Naoki Fujimoto; Shigeki Shibata; Graeme Carrick-Ranson; M Dean Palmer; Kara N Boyd; Beverley Adams-Huet; Benjamin D Levine
Journal:  J Am Coll Cardiol       Date:  2014-09-23       Impact factor: 24.094

9.  The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction.

Authors:  Mark H Drazner; Anand Prasad; Colby Ayers; David W Markham; Jeffrey Hastings; Paul S Bhella; Shigeki Shibata; Benjamin D Levine
Journal:  Circ Heart Fail       Date:  2010-03       Impact factor: 8.790

10.  Congestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanism.

Authors:  Shigeki Shibata; Jeff L Hastings; Anand Prasad; Qi Fu; Paul S Bhella; Eric Pacini; Felix Krainski; M Dean Palmer; Rong Zhang; Benjamin D Levine
Journal:  J Appl Physiol (1985)       Date:  2011-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.